These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11549511)

  • 1. Short-term histopathologic effects of different intracavernosal agents on corpus cavernosum and antifibrotic activity of intracavernosal verapamil: an experimental study.
    Sahin M; Başar MM; Bozdoğan O; Atan A
    Urology; 2001 Sep; 58(3):487-92. PubMed ID: 11549511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological change of corpora cavernosa after long-term intracavernous injection.
    Hwang TI; Yang CR; Ho WL; Chu HW
    Eur Urol; 1991; 20(4):301-6. PubMed ID: 1814746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of different intracavernous vasoactive drugs on cultured endothelial cells of human corpus cavernosum penis.
    Schultheiss D; Pilatz A; Gabouev AI; Schlote N; Wefer J; Mertsching H; Sohn M; Jonas U; Stief CG
    Urology; 2004 Sep; 64(3):598-602. PubMed ID: 15351616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction.
    Chao R; Clowers DE
    Arch Phys Med Rehabil; 1994 Mar; 75(3):276-8. PubMed ID: 8129578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intracavernous calcium channel blockers in dogs.
    Sarikaya S; Aşçi R; Aybek Z; Yilmaz AF; Büyükalpelli R; Yildiz S
    Int Urol Nephrol; 1997; 29(6):673-80. PubMed ID: 9477366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a no-needle penile injector: a preliminary study evaluating tissue penetration and its hemodynamic consequences in the rat.
    Seyam RM; Bégin LR; Tu LM; Dion SB; Merlin SL; Brock GB
    Urology; 1997 Dec; 50(6):994-8. PubMed ID: 9426740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electromyographic changes of corpus cavernosum due to papaverine and nitroprusside in veno-occlusive dysfunction.
    Kayigil O; Atahan O; Metin A
    J Urol; 1996 Oct; 156(4):1316-9. PubMed ID: 8808862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum.
    Leungwattanakij S; Bivalacqua TJ; Usta MF; Yang DY; Hyun JS; Champion HC; Abdel-Mageed AB; Hellstrom WJ
    J Androl; 2003; 24(2):239-45. PubMed ID: 12634311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrical activity of the corpus cavernosum in denervated rats.
    Başar MM; Yildiz M; Başar H; Ak F; Akan H; Atan A
    Int J Urol; 1999 May; 6(5):251-6. PubMed ID: 10375188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local and systemic effects of chronic intracavernous injection of papaverine, prostaglandin E1, and saline in primates.
    Aboseif SR; Breza J; Bosch RJ; Benard F; Stief CG; Stackl W; Lue TF; Tanagho EA
    J Urol; 1989 Aug; 142(2 Pt 1):403-8. PubMed ID: 2746759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intracavernous pressure responses induced by electrical stimulation of penile dorsal nerves and intracavernosal drug injection in rats].
    Xing JP; Cui XF; Sun JH; Li Q; Liu J; Qiu SD
    Zhonghua Nan Ke Xue; 2005 Apr; 11(4):281-3, 287. PubMed ID: 15921260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracavernosal injections and fibrosis: myth or reality?
    Tal R; Mulhall JP
    BJU Int; 2008 Aug; 102(5):525-6. PubMed ID: 18485038
    [No Abstract]   [Full Text] [Related]  

  • 13. Dual Strategy With Oral Phosphodiesterase Type 5 Inhibition and Intracavernosal Implantation of Mesenchymal Stem Cells Is Superior to Individual Approaches in the Recovery of Erectile and Cavernosal Functions After Cavernous Nerve Injury in Rats.
    Martínez-Salamanca JI; Zurita M; Costa C; Martínez-Salamanca E; Fernández A; Castela A; Vaquero J; Carballido J; Angulo J
    J Sex Med; 2016 Jan; 13(1):1-11. PubMed ID: 26755080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K; Brekke I; Christiansen E
    Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peyronie's-like plaque after penile injection of prostaglandin E1.
    Chen J; Godschalk M; Katz PG; Mulligan T
    J Urol; 1994 Sep; 152(3):961-2. PubMed ID: 8051767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erectile response to intracavernous injection of vasoactive drugs after penile prosthesis removal.
    Stief CG; Gall H; Scherb W; Bähren W
    Urology; 1990 Aug; 36(2):143-5. PubMed ID: 2385882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue angiotensin II as a modulator of erectile function. I. Angiotensin peptide content, secretion and effects in the corpus cavernosum.
    Kifor I; Williams GH; Vickers MA; Sullivan MP; Jodbert P; Dluhy RG
    J Urol; 1997 May; 157(5):1920-5. PubMed ID: 9112563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracavernous injection of vasoactive drugs in the rabbit.
    Stackl W; Loupal G; Holzmann A
    Urol Res; 1988; 16(6):455-8. PubMed ID: 3232278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic papaverine treatment: the effect of repeated injections on the simian erectile response and penile tissue.
    Abozeid M; Juenemann KP; Luo JA; Lue TF; Yen TS; Tanagho EA
    J Urol; 1987 Nov; 138(5):1263-6. PubMed ID: 3669186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients.
    Fu Q; Yao DH; Jiang YQ
    Asian J Androl; 2000 Dec; 2(4):301-3. PubMed ID: 11202421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.